nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CYP2E1—prostate cancer	0.133	0.382	CbGaD
Brompheniramine—CYP2C19—prostate cancer	0.132	0.378	CbGaD
Brompheniramine—CYP3A4—prostate cancer	0.084	0.24	CbGaD
Brompheniramine—CYP2C8—Nilutamide—prostate cancer	0.0292	0.0585	CbGbCtD
Brompheniramine—CYP2C19—Bicalutamide—prostate cancer	0.0245	0.0491	CbGbCtD
Brompheniramine—CYP2C19—Nilutamide—prostate cancer	0.0245	0.0491	CbGbCtD
Brompheniramine—CYP2C8—Abiraterone—prostate cancer	0.0242	0.0485	CbGbCtD
Brompheniramine—CYP2E1—Estrone—prostate cancer	0.0234	0.0469	CbGbCtD
Brompheniramine—CYP2B6—Estrone—prostate cancer	0.0231	0.0463	CbGbCtD
Brompheniramine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0226	0.0452	CbGbCtD
Brompheniramine—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0206	0.0412	CbGbCtD
Brompheniramine—CYP2C9—Nilutamide—prostate cancer	0.0204	0.0408	CbGbCtD
Brompheniramine—CYP2C9—Bicalutamide—prostate cancer	0.0204	0.0408	CbGbCtD
Brompheniramine—CYP2C19—Flutamide—prostate cancer	0.0203	0.0407	CbGbCtD
Brompheniramine—CYP2D6—Bicalutamide—prostate cancer	0.0186	0.0373	CbGbCtD
Brompheniramine—CYP2C8—Cabazitaxel—prostate cancer	0.0179	0.0359	CbGbCtD
Brompheniramine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0156	0.0312	CbGbCtD
Brompheniramine—CYP2D6—Abiraterone—prostate cancer	0.0154	0.0309	CbGbCtD
Brompheniramine—CYP2E1—Mitoxantrone—prostate cancer	0.0139	0.0279	CbGbCtD
Brompheniramine—CYP2C9—Estrone—prostate cancer	0.0122	0.0244	CbGbCtD
Brompheniramine—CYP3A4—Bicalutamide—prostate cancer	0.0118	0.0237	CbGbCtD
Brompheniramine—CYP3A4—Estramustine—prostate cancer	0.011	0.0221	CbGbCtD
Brompheniramine—CYP2C8—Estradiol—prostate cancer	0.0101	0.0201	CbGbCtD
Brompheniramine—CYP3A4—Flutamide—prostate cancer	0.00982	0.0197	CbGbCtD
Brompheniramine—CYP3A4—Abiraterone—prostate cancer	0.00982	0.0197	CbGbCtD
Brompheniramine—CYP2C9—Capecitabine—prostate cancer	0.00925	0.0185	CbGbCtD
Brompheniramine—CYP2E1—Etoposide—prostate cancer	0.00879	0.0176	CbGbCtD
Brompheniramine—CYP2C19—Estradiol—prostate cancer	0.00843	0.0169	CbGbCtD
Brompheniramine—CHRM3—ureter—prostate cancer	0.00842	0.232	CbGeAlD
Brompheniramine—CYP3A4—Cabazitaxel—prostate cancer	0.00726	0.0145	CbGbCtD
Brompheniramine—CYP2C19—Prednisone—prostate cancer	0.00725	0.0145	CbGbCtD
Brompheniramine—CYP3A4—Estrone—prostate cancer	0.0071	0.0142	CbGbCtD
Brompheniramine—CYP2C9—Estradiol—prostate cancer	0.00701	0.014	CbGbCtD
Brompheniramine—CYP2C8—Etoposide—prostate cancer	0.00656	0.0131	CbGbCtD
Brompheniramine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00633	0.0127	CbGbCtD
Brompheniramine—CYP2B6—Doxorubicin—prostate cancer	0.00591	0.0118	CbGbCtD
Brompheniramine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00464	0.0093	CbGbCtD
Brompheniramine—CYP3A4—Mitoxantrone—prostate cancer	0.00422	0.00845	CbGbCtD
Brompheniramine—CYP3A4—Estradiol—prostate cancer	0.00408	0.00816	CbGbCtD
Brompheniramine—CYP3A4—Prednisone—prostate cancer	0.00351	0.00702	CbGbCtD
Brompheniramine—CYP2D6—Doxorubicin—prostate cancer	0.00286	0.00572	CbGbCtD
Brompheniramine—CYP3A4—Etoposide—prostate cancer	0.00266	0.00533	CbGbCtD
Brompheniramine—CYP2C19—urine—prostate cancer	0.00254	0.07	CbGeAlD
Brompheniramine—CYP3A4—Docetaxel—prostate cancer	0.00244	0.00488	CbGbCtD
Brompheniramine—CYP2C9—urine—prostate cancer	0.00197	0.0543	CbGeAlD
Brompheniramine—CYP2E1—urine—prostate cancer	0.00187	0.0514	CbGeAlD
Brompheniramine—CYP3A4—Doxorubicin—prostate cancer	0.00182	0.00363	CbGbCtD
Brompheniramine—CYP3A4—urine—prostate cancer	0.0015	0.0414	CbGeAlD
Brompheniramine—CYP2D6—urine—prostate cancer	0.00148	0.0407	CbGeAlD
Brompheniramine—CHRM5—epithelium—prostate cancer	0.00129	0.0355	CbGeAlD
Brompheniramine—CHRM2—prostate gland—prostate cancer	0.00121	0.0332	CbGeAlD
Brompheniramine—CHRM1—prostate gland—prostate cancer	0.0011	0.0302	CbGeAlD
Brompheniramine—CHRM4—testis—prostate cancer	0.000991	0.0273	CbGeAlD
Brompheniramine—CHRM3—prostate gland—prostate cancer	0.000983	0.027	CbGeAlD
Brompheniramine—KCNH2—prostate gland—prostate cancer	0.000871	0.024	CbGeAlD
Brompheniramine—KCNH2—seminal vesicle—prostate cancer	0.000737	0.0203	CbGeAlD
Brompheniramine—HRH1—prostate gland—prostate cancer	0.000698	0.0192	CbGeAlD
Brompheniramine—CYP2E1—prostate gland—prostate cancer	0.000671	0.0185	CbGeAlD
Brompheniramine—CHRM3—renal system—prostate cancer	0.00067	0.0184	CbGeAlD
Brompheniramine—CHRM3—urethra—prostate cancer	0.000658	0.0181	CbGeAlD
Brompheniramine—KCNH2—renal system—prostate cancer	0.000594	0.0163	CbGeAlD
Brompheniramine—KCNH2—urethra—prostate cancer	0.000583	0.0161	CbGeAlD
Brompheniramine—CYP2E1—seminal vesicle—prostate cancer	0.000568	0.0156	CbGeAlD
Brompheniramine—CYP2C8—renal system—prostate cancer	0.000543	0.015	CbGeAlD
Brompheniramine—HRH1—epithelium—prostate cancer	0.000513	0.0141	CbGeAlD
Brompheniramine—CYP2B6—renal system—prostate cancer	0.000487	0.0134	CbGeAlD
Brompheniramine—HRH1—urethra—prostate cancer	0.000468	0.0129	CbGeAlD
Brompheniramine—CYP2E1—renal system—prostate cancer	0.000457	0.0126	CbGeAlD
Brompheniramine—CYP2E1—urethra—prostate cancer	0.000449	0.0124	CbGeAlD
Brompheniramine—KCNH2—bone marrow—prostate cancer	0.000449	0.0124	CbGeAlD
Brompheniramine—CHRM3—testis—prostate cancer	0.000433	0.0119	CbGeAlD
Brompheniramine—KCNH2—testis—prostate cancer	0.000384	0.0106	CbGeAlD
Brompheniramine—CYP3A4—renal system—prostate cancer	0.000368	0.0101	CbGeAlD
Brompheniramine—CYP2D6—renal system—prostate cancer	0.000362	0.00997	CbGeAlD
Brompheniramine—CYP2C8—testis—prostate cancer	0.000351	0.00966	CbGeAlD
Brompheniramine—CYP2B6—testis—prostate cancer	0.000315	0.00867	CbGeAlD
Brompheniramine—HRH1—testis—prostate cancer	0.000308	0.00847	CbGeAlD
Brompheniramine—CYP2E1—testis—prostate cancer	0.000296	0.00814	CbGeAlD
Brompheniramine—KCNH2—lymph node—prostate cancer	0.000278	0.00766	CbGeAlD
Brompheniramine—CYP2D6—testis—prostate cancer	0.000234	0.00644	CbGeAlD
Brompheniramine—HRH1—lymph node—prostate cancer	0.000223	0.00614	CbGeAlD
Brompheniramine—Chlorphenamine—SLC22A1—prostate cancer	0.000215	0.124	CrCbGaD
Brompheniramine—Diphenhydramine—CYP2C18—prostate cancer	0.000178	0.103	CrCbGaD
Brompheniramine—Chlorphenamine—CYP3A5—prostate cancer	0.000173	0.0998	CrCbGaD
Brompheniramine—Tolterodine—CYP2C19—prostate cancer	0.000162	0.0931	CrCbGaD
Brompheniramine—Diphenhydramine—SLC22A1—prostate cancer	0.000146	0.0839	CrCbGaD
Brompheniramine—Carbinoxamine—CYP2E1—prostate cancer	0.00014	0.0807	CrCbGaD
Brompheniramine—Carbinoxamine—CYP2C19—prostate cancer	0.000139	0.0799	CrCbGaD
Brompheniramine—Tolterodine—CYP3A4—prostate cancer	0.000103	0.0592	CrCbGaD
Brompheniramine—Carbinoxamine—CYP3A4—prostate cancer	8.82e-05	0.0508	CrCbGaD
Brompheniramine—Diphenhydramine—CYP2C19—prostate cancer	8e-05	0.0461	CrCbGaD
Brompheniramine—Orphenadrine—CYP2E1—prostate cancer	7.64e-05	0.044	CrCbGaD
Brompheniramine—Chlorphenamine—CYP3A4—prostate cancer	7.5e-05	0.0432	CrCbGaD
Brompheniramine—Promazine—CYP2C19—prostate cancer	6.9e-05	0.0398	CrCbGaD
Brompheniramine—Orphenadrine—CYP3A4—prostate cancer	4.81e-05	0.0277	CrCbGaD
Brompheniramine—Promazine—CYP3A4—prostate cancer	4.39e-05	0.0253	CrCbGaD
Brompheniramine—CHRM3—Signaling Pathways—SERPINE1—prostate cancer	2.04e-06	1.81e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—KRAS—prostate cancer	2.04e-06	1.8e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—KRAS—prostate cancer	2.03e-06	1.79e-05	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	2.03e-06	1.79e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	2.02e-06	1.79e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—KRAS—prostate cancer	2.02e-06	1.79e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—NOS3—prostate cancer	2.01e-06	1.78e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CAV1—prostate cancer	2.01e-06	1.77e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—KRAS—prostate cancer	2e-06	1.77e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—VEGFA—prostate cancer	2e-06	1.77e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—MTHFR—prostate cancer	2e-06	1.77e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SLC5A5—prostate cancer	2e-06	1.77e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—FGF2—prostate cancer	1.99e-06	1.76e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—FGF2—prostate cancer	1.98e-06	1.76e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MTHFR—prostate cancer	1.98e-06	1.75e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—STAT3—prostate cancer	1.98e-06	1.75e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—FGF2—prostate cancer	1.98e-06	1.75e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—NOS3—prostate cancer	1.97e-06	1.74e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NOS3—prostate cancer	1.96e-06	1.74e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PPARA—prostate cancer	1.96e-06	1.74e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—FGF2—prostate cancer	1.96e-06	1.73e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NOS3—prostate cancer	1.96e-06	1.73e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.95e-06	1.73e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NOS3—prostate cancer	1.95e-06	1.73e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PPARA—prostate cancer	1.94e-06	1.72e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—INS—prostate cancer	1.94e-06	1.71e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NOS3—prostate cancer	1.93e-06	1.71e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NQO1—prostate cancer	1.93e-06	1.71e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MYC—prostate cancer	1.92e-06	1.7e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TGFB1—prostate cancer	1.92e-06	1.7e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.92e-06	1.7e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—JAK2—prostate cancer	1.91e-06	1.69e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TH—prostate cancer	1.9e-06	1.68e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—JAK2—prostate cancer	1.9e-06	1.68e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CREBBP—prostate cancer	1.9e-06	1.68e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—JAK2—prostate cancer	1.9e-06	1.68e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EGFR—prostate cancer	1.88e-06	1.66e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—JAK2—prostate cancer	1.88e-06	1.66e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	1.87e-06	1.65e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—PIK3CA—prostate cancer	1.86e-06	1.65e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MDM2—prostate cancer	1.86e-06	1.65e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTEN—prostate cancer	1.86e-06	1.65e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—PIK3CA—prostate cancer	1.86e-06	1.64e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MDM2—prostate cancer	1.86e-06	1.64e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.85e-06	1.64e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.85e-06	1.64e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MDM2—prostate cancer	1.85e-06	1.64e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CAV1—prostate cancer	1.84e-06	1.63e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MYC—prostate cancer	1.84e-06	1.63e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	1.84e-06	1.63e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TGFB1—prostate cancer	1.84e-06	1.63e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ERBB2—prostate cancer	1.84e-06	1.62e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTGS2—prostate cancer	1.84e-06	1.62e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MDM2—prostate cancer	1.83e-06	1.62e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ERBB2—prostate cancer	1.83e-06	1.62e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CAV1—prostate cancer	1.83e-06	1.62e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.83e-06	1.62e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ERBB2—prostate cancer	1.82e-06	1.61e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.81e-06	1.61e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CB—prostate cancer	1.81e-06	1.6e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ERBB2—prostate cancer	1.81e-06	1.6e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CB—prostate cancer	1.81e-06	1.6e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EGFR—prostate cancer	1.8e-06	1.59e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CB—prostate cancer	1.8e-06	1.59e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.8e-06	1.59e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTGS2—prostate cancer	1.8e-06	1.59e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GGT1—prostate cancer	1.79e-06	1.59e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	1.78e-06	1.58e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—KRAS—prostate cancer	1.78e-06	1.57e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—EP300—prostate cancer	1.77e-06	1.57e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.77e-06	1.56e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.75e-06	1.55e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL8—prostate cancer	1.74e-06	1.54e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.74e-06	1.54e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL8—prostate cancer	1.74e-06	1.54e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL8—prostate cancer	1.73e-06	1.53e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—INS—prostate cancer	1.73e-06	1.53e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL8—prostate cancer	1.71e-06	1.52e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—KRAS—prostate cancer	1.7e-06	1.51e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN1B—prostate cancer	1.7e-06	1.5e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—NOS3—prostate cancer	1.7e-06	1.5e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN1B—prostate cancer	1.7e-06	1.5e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CREBBP—prostate cancer	1.69e-06	1.5e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN1B—prostate cancer	1.69e-06	1.49e-05	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	1.68e-06	1.49e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.68e-06	1.49e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—RXRA—prostate cancer	1.68e-06	1.49e-05	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—AKT1—prostate cancer	1.68e-06	1.48e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	1.67e-06	1.48e-05	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—AKT1—prostate cancer	1.67e-06	1.48e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CASP3—prostate cancer	1.67e-06	1.47e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.67e-06	1.47e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2—prostate cancer	1.66e-06	1.47e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CASP3—prostate cancer	1.66e-06	1.47e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2—prostate cancer	1.66e-06	1.47e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CASP3—prostate cancer	1.66e-06	1.46e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—prostate cancer	1.66e-06	1.46e-05	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	1.66e-06	1.46e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2—prostate cancer	1.65e-06	1.46e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—prostate cancer	1.65e-06	1.46e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—prostate cancer	1.65e-06	1.46e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CASP3—prostate cancer	1.64e-06	1.45e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2—prostate cancer	1.64e-06	1.45e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PIK3CA—prostate cancer	1.63e-06	1.44e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—prostate cancer	1.63e-06	1.44e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCND1—prostate cancer	1.62e-06	1.44e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—COMT—prostate cancer	1.62e-06	1.43e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCND1—prostate cancer	1.62e-06	1.43e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCND1—prostate cancer	1.61e-06	1.43e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.61e-06	1.42e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	1.61e-06	1.42e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.61e-06	1.42e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CTNNB1—prostate cancer	1.6e-06	1.42e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTEN—prostate cancer	1.6e-06	1.42e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCND1—prostate cancer	1.6e-06	1.41e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CTNNB1—prostate cancer	1.6e-06	1.41e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—INS—prostate cancer	1.59e-06	1.41e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.58e-06	1.4e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	1.58e-06	1.4e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—prostate cancer	1.58e-06	1.4e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—INS—prostate cancer	1.58e-06	1.39e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP9—prostate cancer	1.57e-06	1.39e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP9—prostate cancer	1.57e-06	1.39e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	1.57e-06	1.39e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.57e-06	1.39e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTEN—prostate cancer	1.57e-06	1.39e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTEN—prostate cancer	1.57e-06	1.39e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP9—prostate cancer	1.56e-06	1.38e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	1.56e-06	1.38e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PIK3CA—prostate cancer	1.56e-06	1.38e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTEN—prostate cancer	1.56e-06	1.38e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN1A—prostate cancer	1.56e-06	1.38e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.56e-06	1.38e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTEN—prostate cancer	1.56e-06	1.38e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS2—prostate cancer	1.55e-06	1.37e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP9—prostate cancer	1.55e-06	1.37e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CREBBP—prostate cancer	1.54e-06	1.37e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	1.54e-06	1.37e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTEN—prostate cancer	1.54e-06	1.36e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—AKT1—prostate cancer	1.53e-06	1.35e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—EP300—prostate cancer	1.53e-06	1.35e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—AKT1—prostate cancer	1.52e-06	1.35e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—AKT1—prostate cancer	1.52e-06	1.34e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—NOS3—prostate cancer	1.52e-06	1.34e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—prostate cancer	1.51e-06	1.34e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	1.5e-06	1.33e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TYMS—prostate cancer	1.5e-06	1.32e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—EP300—prostate cancer	1.5e-06	1.32e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EP300—prostate cancer	1.49e-06	1.32e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EP300—prostate cancer	1.49e-06	1.32e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EP300—prostate cancer	1.48e-06	1.31e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.48e-06	1.31e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.48e-06	1.31e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EP300—prostate cancer	1.47e-06	1.3e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.46e-06	1.3e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—LPL—prostate cancer	1.45e-06	1.28e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SRC—prostate cancer	1.45e-06	1.28e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SRC—prostate cancer	1.45e-06	1.28e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—prostate cancer	1.45e-06	1.28e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SRC—prostate cancer	1.44e-06	1.28e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SRC—prostate cancer	1.43e-06	1.26e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VEGFA—prostate cancer	1.41e-06	1.25e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VEGFA—prostate cancer	1.41e-06	1.25e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VEGFA—prostate cancer	1.41e-06	1.24e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.4e-06	1.24e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—STAT3—prostate cancer	1.4e-06	1.24e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.4e-06	1.24e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—STAT3—prostate cancer	1.4e-06	1.23e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—NOS3—prostate cancer	1.39e-06	1.23e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	1.39e-06	1.23e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—STAT3—prostate cancer	1.39e-06	1.23e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.39e-06	1.23e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS2—prostate cancer	1.39e-06	1.23e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—prostate cancer	1.38e-06	1.22e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—NOS3—prostate cancer	1.38e-06	1.22e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—STAT3—prostate cancer	1.38e-06	1.22e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTEN—prostate cancer	1.36e-06	1.2e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—AKT1—prostate cancer	1.33e-06	1.18e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PIK3CA—prostate cancer	1.31e-06	1.16e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.31e-06	1.16e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MYC—prostate cancer	1.3e-06	1.15e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TGFB1—prostate cancer	1.3e-06	1.15e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MYC—prostate cancer	1.3e-06	1.15e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TGFB1—prostate cancer	1.29e-06	1.14e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MYC—prostate cancer	1.29e-06	1.14e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—EP300—prostate cancer	1.29e-06	1.14e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TGFB1—prostate cancer	1.29e-06	1.14e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.29e-06	1.14e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PPARA—prostate cancer	1.28e-06	1.13e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MYC—prostate cancer	1.28e-06	1.13e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—AKT1—prostate cancer	1.28e-06	1.13e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	1.28e-06	1.13e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.28e-06	1.13e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.28e-06	1.13e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EGFR—prostate cancer	1.27e-06	1.13e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EGFR—prostate cancer	1.27e-06	1.12e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS2—prostate cancer	1.26e-06	1.12e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EGFR—prostate cancer	1.26e-06	1.12e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EGFR—prostate cancer	1.25e-06	1.11e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTEN—prostate cancer	1.21e-06	1.07e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CAV1—prostate cancer	1.21e-06	1.07e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—KRAS—prostate cancer	1.2e-06	1.06e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—KRAS—prostate cancer	1.2e-06	1.06e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—KRAS—prostate cancer	1.19e-06	1.06e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—KRAS—prostate cancer	1.18e-06	1.05e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—EP300—prostate cancer	1.15e-06	1.02e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CA—prostate cancer	1.13e-06	9.99e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTEN—prostate cancer	1.11e-06	9.84e-06	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CA—prostate cancer	1.11e-06	9.78e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	1.1e-06	9.77e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTEN—prostate cancer	1.1e-06	9.76e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	1.1e-06	9.74e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.1e-06	9.72e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	1.1e-06	9.71e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	1.09e-06	9.62e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—AKT1—prostate cancer	1.07e-06	9.49e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—prostate cancer	1.07e-06	9.45e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—prostate cancer	1.07e-06	9.42e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—prostate cancer	1.06e-06	9.39e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—EP300—prostate cancer	1.06e-06	9.39e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—EP300—prostate cancer	1.05e-06	9.3e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—prostate cancer	1.05e-06	9.3e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—INS—prostate cancer	1.04e-06	9.2e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.02e-06	9.01e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—prostate cancer	9.78e-07	8.65e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—prostate cancer	9.75e-07	8.63e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—prostate cancer	9.72e-07	8.6e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CD—prostate cancer	9.66e-07	8.54e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—prostate cancer	9.62e-07	8.51e-06	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CA—prostate cancer	9.56e-07	8.46e-06	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—AKT1—prostate cancer	9.22e-07	8.16e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NOS3—prostate cancer	9.12e-07	8.07e-06	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—AKT1—prostate cancer	9.04e-07	7.99e-06	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—AKT1—prostate cancer	9.02e-07	7.98e-06	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—AKT1—prostate cancer	8.99e-07	7.96e-06	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—AKT1—prostate cancer	8.97e-07	7.93e-06	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—AKT1—prostate cancer	8.88e-07	7.85e-06	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CA—prostate cancer	8.53e-07	7.55e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CB—prostate cancer	8.42e-07	7.45e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS2—prostate cancer	8.34e-07	7.38e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CA—prostate cancer	7.85e-07	6.94e-06	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—AKT1—prostate cancer	7.81e-07	6.91e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CA—prostate cancer	7.78e-07	6.88e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTEN—prostate cancer	7.27e-07	6.43e-06	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AKT1—prostate cancer	6.97e-07	6.17e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—EP300—prostate cancer	6.94e-07	6.14e-06	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AKT1—prostate cancer	6.41e-07	5.67e-06	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AKT1—prostate cancer	6.36e-07	5.62e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.13e-07	4.54e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AKT1—prostate cancer	4.19e-07	3.71e-06	CbGpPWpGaD
